Nano Labs Announces First Half of 2022 Financial Results
Nano Labs Ltd (Nasdaq: NA) reported significant financial growth for the first half of 2022, with net revenue soaring to RMB380.1 million (US$56.6 million), up 1,565.5% from RMB22.8 million in 2021. Gross profit also surged to RMB176.4 million (US$26.3 million). The company achieved net income of RMB111.4 million (US$16.6 million), rebounding from a loss of RMB33.3 million in the same period last year. The earnings per share rose to RMB1.07 (US$0.16). Despite challenges in the cryptocurrency market and the COVID-19 pandemic, Nano Labs began mass production of its Cuckoo 2.0 chip and expanded its international sales network.
- Net revenue increased 1,565.5% to RMB380.1 million (US$56.6 million).
- Gross profit rose to RMB176.4 million (US$26.3 million).
- Net income turned positive at RMB111.4 million (US$16.6 million) from a net loss of RMB33.3 million.
- Earnings per share improved to RMB1.07 (US$0.16) from a loss of RMB0.38.
- Mass production of Cuckoo 2.0 chip initiated.
- Expansion of international sales network and significant growth in online mall traffic.
- Cost of revenues increased by 1,660.4% to RMB203.8 million (US$30.4 million), outpacing revenue growth.
- Operating expenses rose by 51.2% to RMB68.7 million (US$10.2 million).
- Cash and cash equivalents decreased to RMB51.4 million (US$7.7 million) from RMB233.9 million as of December 31, 2021.
HANGZHOU, China, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading fabless integrated circuit design company and product solution provider in China, today announced its unaudited financial results as of June 30, 2022 and for the first half of 2022 then ended.
First Half of 2022 Financial Highlights
- Net revenue increased significantly to RMB380.1 million (US
$56.6 million ) from RMB22.8 million in the same period of 2021. - Gross profit increased significantly to RMB176.4 million (US
$26.3 million ) from RMB11.2 million for the same period of 2021. - Profit from operations was RMB107.6 million (US
$16.0 million ) for the first half of 2022, compared to a loss from operations of RMB34.2 million in the same period of 2021. - Net income was RMB111.4 million (US
$16.6 million ) for the first half of 2022, compared to a net loss of RMB33.3 million in the same period of 2021. - Earnings per share (both basic and diluted) was RMB1.07 (US
$0.16) for the first half of 2022, compared to a loss per share (both basic and diluted) of RMB0.38 in the same period of 2021.
Mr. Jianping Kong, Chairman and Chief Executive Officer of the Company, commented, “Despite the downtrend in the prices of cryptocurrencies and the resurgence of the COVID-19 pandemic, we had a successful first half of 2022 evidenced by our robust performance. We started the mass production of our Cuckoo 2.0 in the first half of 2022. By completing our Cuckoo 2.0’s whole re-distributed layer (“RDL”) advanced packaging test recently, Nano Labs has become the first fabless IC design company to achieve wafer-level RDL packaging for chips with an area of 800 mm² and finished product up to 1600 mm². In addition, we have achieved the mass production of Cuckoo 2.0 SE chip, and the design of Cuckoo 3.0 has progressed as planned. We have also been expanding our overseas sales network, and there has been a significant increase in international traffic to our official online mall. Leveraging our in-depth industry understanding and experiences, we intend to seize opportunities in the Metaverse market by investing in the development of more cutting-edge technologies, such as privacy-preserving computing and autostereoscopic technology as well as Ipolloverse, our Metaverse computing network platform, which has passed the internal testnet and expect to release the public test network before the end of this year.”
Mr. Bing Chen, Chief Financial Officer, commented, “During the first half of 2022, we achieved a significant growth in net revenues, with an increase of 1,
First Half of 2022 Financial Results
Net Revenues
Net revenues increased significantly by 1,
Cost of Revenues
Cost of revenues increased significantly by 1,
Operating Expenses
Total operating expenses increased by
- Selling and marketing expenses increased significantly to RMB10.2 million (US
$1.5 million ) for the first half of 2022 from RMB0.04 million for the same period of 2021. The increase in selling and marketing expenses was primarily due to the increase in advertising expenses to support marketing strategies, expand market share and improve brand visibility and the increase in employee salary expenses due to the increased headcount in sales and marketing personnel. - General and administrative expenses increased by
46.9% to RMB16.9 million (US$2.5 million ) for the first half of 2022, from RMB11.5 million for the same period of 2021. The increase in general and administrative expenses was primarily due to the increase in employee salary expenses as the number and salaries of general and administrative staff increased due to the development and expansion of its business. - Research and development expenses increased by
22.9% to RMB41.7 million (US$6.2 million ) for the first half of 2022, from RMB33.9 million for the same period of 2021. The increase in research and development expenses was primarily due to the increase in employee salary expenses and share-based compensation expenses as a result of an increased number of research and development personnel as well as their salaries, partially offset by a decrease in design and service fee. The Company expects to continue its significant investment in research and development to support its future development, product iteration, and competitive strengths.
Profit (Loss) from Operations
Profit from operations was RMB107.6 million (US
Finance Expenses (Income)
Finance income was RMB0.6 million (US
Interest Income
Interest income increased by
Other Income
Other income increased by
Net Income (Loss)
Net income was RMB111.4 million (US
Basic and diluted earnings per share was RMB1.07 (US
Cash and Cash Equivalents
As of June 30, 2022, the Company had cash and cash equivalents of RMB51.4 million (US
Recent Development
On July 14, 2022, the Company completed its initial public offering of 1,770,000 American Depositary Shares (“ADS”) at a price to the public of US
Exchange Rate
This press release contains translations of certain Renminbi (RMB) amounts into U.S. dollars (US$) solely for the convenience of the reader. Unless otherwise specified, all translations of Renminbi amounts into U.S. dollar amounts in this press release are made at RMB 6.7114 to US
Non-GAAP Financial Measures
In evaluating our business, we consider and use adjusted net income (loss) as an additional non-GAAP measure to review and assess our operating performance. The presentation of the non-GAAP financial measure is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. We define adjusted net income (loss) as net income (loss) excluding share-based compensation expense.
We present the non-GAAP financial measure because they are used by our management to evaluate our operating performance and formulate business plans. Non-GAAP financial measures enable our management to assess our operating results without considering the impact of non-cash charges and non-operating items. We also believe that the use of the non-GAAP measure facilitates investors’ assessment of our operating performance.
The non-GAAP financial measure is not defined under U.S. GAAP and is not presented in accordance with U.S. GAAP. The non-GAAP financial measure has limitations as analytical tools. One of the key limitations of using the non-GAAP financial measure is that they do not reflect all items of income and expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of adjusted net income (loss). Further, the non-GAAP measure may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited.
About Nano Labs Ltd
Nano Labs Ltd is a leading fabless integrated circuit (“IC”) design company and product solution provider in China. Nano Labs is committed to the development of high throughput computing (“HTC”) chips, high performance computing (“HPC”) chips, distributed computing and storage solutions, smart network interface cards (“NICs”) vision computing chips and distributed rendering. Nano Labs has built a comprehensive flow processing unit (“FPU”) architecture which offers solution that integrates the features of both HTC and HPC. Nano Lab’s Cuckoo series are one of the first near-memory HTC chips available in the market*. For more information, please visit the Company’s website at: ir.nano.cn.
*According to an industry report prepared by Frost & Sullivan.
Forward-Looking Statements
This report contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, the Company’s plan to appeal the Staff’s determination, which can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Such statements are based upon management’s current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control, which may cause the Company’s actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
For investor and media inquiries, please contact:
Nano Labs Ltd
Email: ir@nano.cn
Ascent Investor Relations LLC
Ms. Tina Xiao
Tel: (917) 609-0333
Email: tina.xiao@ascent-ir.com
| Consolidated Balance Sheets | |||||||||
| (all amounts in RMB and US$, except number of shares or as otherwise noted) | |||||||||
| As of December 31, | As of June 30, | ||||||||
| 2021 | 2022 | ||||||||
| RMB | RMB | US$ | |||||||
| (Unaudited) | (Unaudited) | ||||||||
| ASSETS | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | 233,853,654 | 51,409,197 | 7,659,981 | ||||||
| Short-term investments | 31,888,500 | - | - | ||||||
| Inventories, net | 213,870,251 | 392,691,276 | 58,511,082 | ||||||
| Prepayments | 372,355,129 | 264,126,602 | 39,354,919 | ||||||
| Other current assets | 41,460,490 | 35,372,460 | 5,270,504 | ||||||
| Total current assets | 893,428,024 | 743,599,535 | 110,796,486 | ||||||
| Non-current assets: | |||||||||
| Property and equipment, net | 7,249,044 | 6,713,620 | 1,000,331 | ||||||
| Intangible asset, net | - | 49,210,055 | 7,332,308 | ||||||
| Operating lease right-of-use assets | 9,155,665 | 6,618,669 | 986,183 | ||||||
| Total non-current assets | 16,404,709 | 62,542,344 | 9,318,822 | ||||||
| TOTAL ASSETS | 909,832,733 | 806,141,879 | 120,115,308 | ||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) | |||||||||
| Current liabilities: | |||||||||
| Accounts payable | 2,837,638 | 7,313,610 | 1,089,729 | ||||||
| Advance from customers | 917,391,899 | 696,894,165 | 103,837,376 | ||||||
| Operating lease liabilities, current | 5,224,757 | 3,429,724 | 511,030 | ||||||
| Other current liabilities | 6,917,757 | 4,350,494 | 648,223 | ||||||
| Total current liabilities | 932,372,051 | 711,987,993 | 106,086,358 | ||||||
| Non-current liabilities: | |||||||||
| Operating lease liabilities, non-current | 2,122,357 | 1,411,472 | 210,310 | ||||||
| Total liabilities | 934,494,408 | 713,399,465 | 106,296,668 | ||||||
| Shareholders' equity (deficit): | |||||||||
| Ordinary shares ( | 66,970 | 66,970 | 9,979 | ||||||
| Additional paid-in capital | 201,418,380 | 206,092,053 | 30,707,759 | ||||||
| Accumulated deficit | (223,679,698 | ) | (112,286,174 | ) | (16,730,663 | ) | |||
| Accumulated other comprehensive loss | (2,467,327 | ) | (1,130,435 | ) | (168,435 | ) | |||
| Total shareholders' equity (deficit) | (24,661,675 | ) | 92,742,414 | 13,818,640 | |||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) | 909,832,733 | 806,141,879 | 120,115,308 | ||||||
| Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss) | ||||||||
| (all amounts in RMB and US$, except number of shares or as otherwise noted) | ||||||||
| For the six months ended June 30, | ||||||||
| 2021 | 2022 | |||||||
| RMB | RMB | US$ | ||||||
| Net revenues | 22,823,678 | 380,138,767 | 56,640,756 | |||||
| Cost of revenues | 11,574,779 | 203,767,419 | 30,361,388 | |||||
| Gross profit | 11,248,899 | 176,371,348 | 26,279,368 | |||||
| Operating expenses: | ||||||||
| Selling and marketing expenses | 43,870 | 10,165,237 | 1,514,622 | |||||
| General and administrative expenses | 11,497,795 | 16,885,396 | 2,515,928 | |||||
| Research and development expenses | 33,929,137 | 41,692,574 | 6,212,202 | |||||
| Total operating expenses | 45,470,802 | 68,743,207 | 10,242,752 | |||||
| Profit (loss) from operations | (34,221,903 | ) | 107,628,141 | 16,036,616 | ||||
| Other expenses (income) : | ||||||||
| Finance expense (income) | 132,914 | (636,158 | ) | (94,788 | ) | |||
| Interest income | (619,876 | ) | (1,860,642 | ) | (277,236 | ) | ||
| Other income | (393,876 | ) | (1,268,583 | ) | (189,019 | ) | ||
| Total other income | (880,838 | ) | (3,765,383 | ) | (561,043 | ) | ||
| Income (loss) before income tax provision | (33,341,065 | ) | 111,393,524 | 16,597,659 | ||||
| Income tax provision | - | - | - | |||||
| Net income (loss) | (33,341,065 | ) | 111,393,524 | 16,597,659 | ||||
| Comprehensive income (loss): | ||||||||
| Net income (loss) | (33,341,065 | ) | 111,393,524 | 16,597,659 | ||||
| Other comprehensive income: | ||||||||
| Foreign currency translation adjustment | - | 1,336,892 | 199,197 | |||||
| Total comprehensive income (loss) | (33,341,065 | ) | 112,730,416 | 16,796,856 | ||||
| Net income (loss) per ordinary share: | ||||||||
| Basic | (0.38 | ) | 1.07 | 0.16 | ||||
| Diluted | (0.38 | ) | 1.07 | 0.16 | ||||
| Weighted average number of shares used in per share calculation: | ||||||||
| Basic | 87,202,791 | 103,790,000 | 103,790,000 | |||||
| Diluted | 87,202,791 | 103,902,581 | 103,902,581 | |||||
| Non-GAAP Reconciliation | ||||||
| (all amounts in RMB and US$)(Unaudited) | ||||||
| For the Six Months Ended June 30, | ||||||
| 2021 | 2022 | |||||
| RMB | RMB | US$ | ||||
| Net income (Loss) | (33,341,065 | ) | 111,393,524 | 16,597,659 | ||
| Add: | ||||||
| Share-based compensation expenses | 9,672 | 4,673,673 | 696,378 | |||
| Non-GAAP adjusted net income (Loss) | (33,331,393 | ) | 116,067,197 | 17,294,037 | ||
FAQ
What were Nano Labs' financial results for the first half of 2022?
How much did Nano Labs' revenue increase compared to the previous year?
What is the earnings per share for Nano Labs for H1 2022?
Did Nano Labs achieve any significant product milestones in 2022?
How did Nano Labs' operating expenses change in H1 2022?
